USE OF A PROTEIN PHOSPHORILATION MODULATOR AS A MEDICATION IN THE TREATMENT OF AMYLOIDOSIS ASSOCIATED WITH ALZHEIMER DISEASE.

摘要

DESCRIBES THE USE OF AT LEAST ONE KINASE MODULATOR OR A PHOSPHATASE MODULATOR ABLE TO INCREASE OR REDUCE THE SPEED OF THE PROTEOLYTIC PROCESSING OF THE PROTEINS IN THE LAURA AND INAULAR COMPLEXES IN THE LAURA FOR THE TREATMENT OF AMYLOIDOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE, WHERE SUCH PHARMACEUTICAL COMPOSITION CONTAINS SUCH MODULATOR IN AN AMOUNT THAT EFFECTIVELY REGULATES THE PHOSPHORILATION OF SUCH PROTEINS.